HEMA Stock News 0.1700 05/07/2014 13:38:44 Hemacare Corp (HE

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hemacare Corp (HEMA) 0.1700 $HEMA

2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018
M2 - Wed Jan 22, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/ft7f6d/apheresis) has announced the addition of the "2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018" report to their offering. This report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipment used in apheresis. The report provides in-depth analysis of the sub-segments of the market with their estimated forecast of market size from 2010 to 2018. The data analyses the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. This research is specifically prepared to analyze and estimate the performance of the major apheresis equipment segments in the global market. The study also presents a comprehensive assessment of the major strategies of the market stakeholders and their winning imperatives by segmenting the market as follows: Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 4 Global Apheresis Equipment Market, By Applications 5 Apheresis Equipment Market, By Types Of Procedures 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/ft7f6d/apheresis

Global Apheresis Equipment Market Report 2013 - 2018
M2 - Mon Nov 18, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/jlpwt8/apheresis) has announced the addition of the "Global Apheresis Equipment Market Report 2013 - 2018" report to their offering. The applications equipment market is classified on the basis of types of clinical areas in which the apheresis procedure is employed. The report covers the analysis of the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. Further, this report also covers the major firms that are active in the apheresis market. The company profiles included in the report will be of significant help in understanding the tactical overview of the market. The company profiling performed in the report covers the financial and strategic properties, SWOT analysis, and the recent developments of the major players of the global apheresis market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 3.1 Introduction 3.2 Therapeutic Apheresis 3.3 Donor Apheresis 3.4 Market Dynamics 3.5 Porter's Five Forces Analysis 3.6 Market Attractiveness Analysis 3.7 Market Share Analysis, 2011 4 Global Apheresis Equipment Market, By Applications 4.1 Introduction 4.2 Neurological Disorders 4.3 Hematology 4.4 Renal Disorders 4.5 Others 5 Apheresis Equipment Market, By Types Of Procedures 5.1 Introduction 5.2 Plasmapheresis 5.3 Photopheresis 5.4 Leukapheresis 5.5 Plateletpheresis 5.6 LDL Apheresis 5.7 Erythrocytapheresis 5.8 Others (Lymphapheresis, Lipidpheresis) 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 7.1 Introduction 7.2 North America 7.3 Europe 7.4 Asia Pacific 7.5 Rest Of World 8 Competitive Landscape 8.1 Introduction 8.2 Major Strategies By Key Players 8.3 Recommendations 9 Company Profiles Companies Mentioned - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/jlpwt8/apheresis

BioLife Solutions Announces Strategic Partnership with HemaCare
PR Newswire - Tue Jun 25, 5:00AM CDT
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol® and CryoStor® biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.

HemaCare Reports Improved Six Month and Year End Results
Business Wire - Mon Mar 18, 8:00AM CDT
HemaCare Corporation (HEMA) today reported its financial results for the six months and year ended December 31, 2012. For the six month period, revenue rose by 13% to $9.2 million, while the loss from continuing operations decreased by 83% to $214,000 when compared to the year-earlier period. For the year ended December 31, 2012, revenue rose by 10% to $17.9 million, while the loss from continuing operations decreased by 65% to $758,000 compared to the year-earlier period. Total Company income was $1,163,000 for the year ended December 31, 2012 compared with a total Company loss of $805,000 for the year ended December 31, 2011.

Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
M2 - Thu Feb 28, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztn2dt/apheresis) has announced the addition of the "Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis in Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines and Disposable Kits) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 This report on the global apheresis equipment market includes the different facets of therapeutic apheresis, donor apheresis, and the apheresis devices market. The report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipmen

Apheresis Market - Applications, Procedures, Devices & Disposables - Forecasts To 2017
M2 - Wed Jan 16, 9:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/sfgngk/apheresis_market) has announced the addition of the "Apheresis Market - Applications (Plasmapheresis, Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts To 2017" report to their offering. Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Growth Outlook for the Packaging Robots Market to 2032

Updated Category News Views 128

The Expanding Landscape of Packaging Robots The Packaging Robots Market is on an exciting trajectory, projected to soar from an estimated USD 6.02 billion in 2023 to an impressive USD 16.67 billion by 2032. This remarkable growth is fueled by continuous technological advancements and the ever-increasing demand for automation, as businesses strive for greater efficiency in...

Continue Reading
Analyzing the Short Interest Trends for AutoZone Inc

Updated Category News Views 88

Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...

Continue Reading
Join the Fight: Investors Urged to Act Against Flywire's Missteps

Updated Category News Views 180

Critical Insights into Flywire Corporation's Recent Challenges In light of recent events, investors in Flywire Corporation (NASDAQ: FLYW) are presented with a pivotal opportunity to address potential securities fraud claims. Allegations suggest that the company might have communicated misleading business information to the public, raising concerns among its shareholders....

Continue Reading
LEPAS L8: A Game-Changer for Electric Vehicle Enthusiasts

Updated Category News Views 308

LEPAS L8: Redefining the Future of NEVs The innovative leap forward in the world of electric vehicles comes with Chery Group's brand new energy vehicle (NEV) brand, LEPAS, and its latest offering, the L8 model. The introduction of the L8 marks a significant milestone for Chery as it establishes a new standard in driving sophistication. This model is poised to make waves...

Continue Reading
Integra LifeSciences Launches Pediatric Registry for AERA System

Updated Category News Views 128

Integra LifeSciences Initiates Pediatric AERA Registry Integra LifeSciences Holding Corporation (Nasdaq: IART), a premier global leader in medical technology, has taken a significant step forward by enrolling the first patient in the Acclarent AERA Pediatric Registry. This multi-center observational registry aims to evaluate the real-world applications of the AERA...

Continue Reading